The market expects Ironwood Pharmaceuticals (IRWD) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2022. This widely-known ...
Ironwood Pharmaceuticals has established itself as a leader in the gastrointestinal healthcare space with its innovative products and pipeline development. The demand for LINZESS, a therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results